These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

920 related articles for article (PubMed ID: 1982234)

  • 1. Selective unilateral inactivation of striatal D1 and D2 dopamine receptor subtypes by EEDQ: turning behavior elicited by D2 dopamine receptor agonists.
    Giorgi O; Biggio G
    Brain Res; 1990 Nov; 533(1):53-9. PubMed ID: 1982234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unilateral inactivation of dopamine receptors after intrastriatal injection of N-ethoxy-carbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ): a novel rotational model to investigate dopamine receptor interactions.
    Giorgi O; Biggio G
    Pharmacol Biochem Behav; 1990 Apr; 35(4):877-84. PubMed ID: 1971721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nigral D1 and striatal D2 receptors mediate the behavioral effects of dopamine agonists.
    LaHoste GJ; Marshall JF
    Behav Brain Res; 1990 May; 38(3):233-42. PubMed ID: 1973041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An autoradiographic study of the differential effects of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) on striatal and extrastriatal D-1 and D-2 dopamine receptors in the rat.
    Gnanalingham KK; Hunter AJ; Jenner P; Marsden CD
    Neuropharmacology; 1994 May; 33(5):647-55. PubMed ID: 7936100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine receptor occupancy in vivo: measurement using N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ).
    Saller CF; Kreamer LD; Adamovage LA; Salama AI
    Life Sci; 1989; 45(10):917-29. PubMed ID: 2529407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of inactivation of D1 dopamine receptors on stereotypic and thermic responses to quinpirole (LY 171555).
    Double KL; Crocker AD
    Neurosci Lett; 1990 Jul; 115(1):81-5. PubMed ID: 1977110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Day/night differences in D1 but not D2 DA receptor protection from EEDQ denaturation in rats treated with continuous cocaine.
    Burger LY; Martin-Iverson MT
    Synapse; 1993 Jan; 13(1):20-9. PubMed ID: 8093985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective protection from the inhibition by EEDQ of D1 and D2 dopamine agonist-induced rotational behavior in mice.
    Goodale DB; Jacobi AG; Seyfried DM; Weiss B
    Pharmacol Biochem Behav; 1988 Jun; 30(2):457-62. PubMed ID: 2902647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT; White FJ
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of D1 and D2 dopamine receptors in oral stereotypy induced by dopaminergic stimulation of the ventrolateral striatum.
    Delfs JM; Kelley AE
    Neuroscience; 1990; 39(1):59-67. PubMed ID: 1982467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo assessment of release and metabolism of dopamine in the ventrolateral striatum of awake rats following administration of dopamine D1 and D2 receptor agonists and antagonists.
    See RE; Sorg BA; Chapman MA; Kalivas PW
    Neuropharmacology; 1991 Dec; 30(12A):1269-74. PubMed ID: 1686300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EEDQ, a tool for ex vivo measurement of occupancy of D-1 and D-2 dopamine receptors.
    Nowak G; Arnt J; Hyttel J
    Eur J Pharmacol; 1988 Aug; 153(2-3):309-11. PubMed ID: 3053212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective inactivation of dopamine D1 and D2 receptors in 6-hydroxydopamine-lesioned rats: evidence that the effect of D1 and D2 agonists can be expressed in the absence of the heterologous DA receptor.
    Arnt J; Hyttel J
    Pharmacol Toxicol; 1989 Jan; 64(1):116-9. PubMed ID: 2526946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parametric and pharmacological analyses of the enhanced grooming response elicited by the D1 dopamine receptor agonist SKF 38393 in the rat.
    Wachtel SR; Brooderson RJ; White FJ
    Psychopharmacology (Berl); 1992; 109(1-2):41-8. PubMed ID: 1365670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
    LaHoste GJ; Marshall JF
    Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of chronic dopamine D1 and D2 receptor agonists on rotational behavior and dopamine receptor binding.
    Engber TM; Marin C; Susel Z; Chase TN
    Eur J Pharmacol; 1993 Jun; 236(3):385-93. PubMed ID: 8102970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. D1-like and D2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease.
    Paul ML; Graybiel AM; David JC; Robertson HA
    J Neurosci; 1992 Oct; 12(10):3729-42. PubMed ID: 1357113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeated stimulation of D1 dopamine receptors causes time-dependent alterations in the sensitivity of both D1 and D2 dopamine receptors within the rat striatum.
    Hu XT; Brooderson RJ; White FJ
    Neuroscience; 1992 Sep; 50(1):137-47. PubMed ID: 1357592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anatomical localization of SKF-38393-induced behaviors in rats using the irreversible monoamine receptor antagonist EEDQ.
    Neisewander JL; Ong A; McGonigle P
    Synapse; 1995 Feb; 19(2):134-43. PubMed ID: 7725242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.